New Token Deal Lets Dental Tech Raise Money on Solana

A joint effort by First Block, Onpharma and Crito Capital has kicked off what appears to be the first time a U. S. operating company uses Solana’s blockchain to sell tokenised shares. The move is seen as a milestone that could streamline how private markets raise capital worldwide. The plan uses Solana’s fast, low‑cost network to issue and settle tokens that represent real ownership in Onpharma. Because the offering is structured as a Regulation S offshore deal, it can reach investors outside the U. S. while staying compliant with securities rules. Onpharma specializes in a dental product called the Onset EZ Pen. The pen speeds up local anaesthetic and makes injections more comfortable, a problem that has persisted for years. The device already sees millions of uses each year and is expected to grow as more dentists adopt the technology.

The company sits at a key growth stage: production, supply chain and regulatory approvals are complete, but sales are still ramping up. The new capital will help expand field‑sales teams and leverage AI tools for marketing, aiming to tap a market that could reach $2. 65 billion by 2030. First Block’s role is to provide a fully digital securities platform that handles everything from compliance checks to on‑chain settlement. This reduces the need for multiple intermediaries, cutting costs and speeding up transactions. Crito Capital brings banking expertise to the deal, structuring the offering for institutional investors and ensuring it meets regulatory standards. If successful, this venture could signal a broader shift toward tokenised securities for real‑world businesses, making fundraising faster and more accessible.

Actions